Ovarian Stimulation Clinical Trial
Official title:
A Prospective, Randomized, Controlled Trial Comparing Three Different Gonadotrophin Regimens in Oocyte Donors: Ovarian Response and IVF Outcome
Exploratory study assessing the effect of three gonadotrophin protocols on Controlled Ovarian Stimulation (COS) parameters and IVF outcome in oocyte donors undergoing GnRH analogue (long protocol). 1,028 donors were randomized in three groups: Group I (n= 346) only r-FSH, Group II (n= 333) only HP-hMG and Group III (n= 349) r-FSH plus HP-hMG. IVF outcome of 1,059 oocyte recipients was compared.
Status | Completed |
Enrollment | 0 |
Est. completion date | December 2006 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 34 Years |
Eligibility |
Inclusion Criteria: - healthy women 18-34 years of age - regular menstrual cycles - no family history of hereditary or chromosomal diseases - normal karyotype - BMI 18-29 Kg/m2 - negative screening for sexually transmitted diseases Exclusion Criteria: - women with PCOS were not included in this study |
N/A
Country | Name | City | State |
---|---|---|---|
Spain | IVI Valencia | Valencia |
Lead Sponsor | Collaborator |
---|---|
Instituto Valenciano de Infertilidad, IVI VALENCIA |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The aim of this study was to verify whether different gonadotrophin regimes could affect controlled ovarian stimulation (COS) parameters and IVF outcome in an egg donation program. | one year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01121991 -
A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive Technologies
|
Phase 3 | |
Not yet recruiting |
NCT04539067 -
Effect of Controlled Ovarian Stimulation in Quality of Oocyte and Embryo
|
Phase 2 | |
Recruiting |
NCT02715336 -
Efficacy and Safety of Medication Used to Stimulate Ovulation
|
Phase 4 | |
Not yet recruiting |
NCT03298750 -
Mechanical Stimulation of the Ovary for Infertility Treatment in Patients With Very Low Ovarian Reserve
|
N/A | |
Completed |
NCT03939403 -
Conventional Ovarian Stimulation vs. Single Injection Stimulation of Corifollitropin Alfa in Oocyte Donor
|
Phase 4 | |
Recruiting |
NCT06142708 -
The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger
|
N/A | |
Recruiting |
NCT05166668 -
Letrozole /GnRH Antagonist Protocol in Women Over 40 Years Undergoing ICSI Cycle
|
N/A | |
Completed |
NCT04549649 -
The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response
|
N/A | |
Terminated |
NCT01816789 -
Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles
|
Phase 4 | |
Completed |
NCT00823004 -
Antagonist/Letrozole in Poor Responders
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06175832 -
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
|
Phase 4 | |
Completed |
NCT01145144 -
Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment
|
N/A | |
Completed |
NCT00830492 -
Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist
|
Phase 4 | |
Completed |
NCT01037699 -
Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles
|
Phase 3 | |
Completed |
NCT01112358 -
Lutropin Alfa in Women at Risk of Poor Response
|
Phase 2 | |
Recruiting |
NCT03400722 -
Double Ovarian Stimulation as Accumulation Strategy for Older Infertile Patients With Suboptimal Ovarian Response
|
Phase 4 | |
Completed |
NCT00669786 -
Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles
|
Phase 3 |